2016
HBsAg immune-escape Mutations and Stop-Codons, Circulating among European HBV-chronically infected patients can impact on HBV transmission and disease progression
Oral Presentation by Luna Colagrossi
14th european Meeting on HIV & Hepatitis.
Poster presentation by Valentina Svicher
European Association for the Study of the Liver (EASL) 2016
2015
Treatment Strategies for HIV/ Hepatitis infected Patients European guidance on clinical management of HIV low level viremia
Oral abstract presentation by Marije Hofstra
13th HIV and Hepatitis meeting Barcelona 3-5 June 2015
Transmission of Drug Resistance in Europe: Overview of SPREAD Surveillance Program
Oral abstract by Marije Hofstra
13th HIV and Hepatitis meeting Barcelona 3-5 June 2015
The global spread of HIV-1 subtype A epidemic: a phylogeographic analysis
Oral abstract by Dimitrios Pareskevis
13th HIV and Hepatitis meeting Barcelona 3-5 June 2015
Molecular epidemiology of HIV-1 in Scandinavia
Oral abtract by Jan Albert
13th HIV and Hepatitis meeting Barcelona 3-5 June 2015
Geopolitical effects in the epidemiology of HIV-1 subtype
Poster presentation by Dimitrios Paraskevis
Conference on Retroviruses and Opportunistic Infections (CROI 2015) 26 February 2015
2014
The global spread of HIV-1 CRF01_AE epidemic: a phylogeographic analysis
Poster presentation by Dimitrios Paraskevis
20th International AIDS Conference (AIDS 2014), 20-25 July 2014, Melbourne, Australia
Migrants have a higher risk of presenting in an advanced stage of HIV infection compared to natives, particularly heterosexual and non-European migrants
Oral abstract presentation by Marije Hofstra
Conference: 5th European Conference on Migrant and Ethnic Minority Health, 10-12 April 2014, Granada, Spain
Prevalence of resistance mutations associated with decreased susceptibility to rilpivirine in antiretroviral naïve patients from Europe
Oral abstract presentation by Marije Hofstra
12th European Workshop on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance, 26 - 28 March 2014, Barcelona, Spain
Primary Resistance to Integrase Strand-Transfer Inhibitors in Europe
Poster presentation by Maria Casadellà Fontdevila
12th European Workshop on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance, 26 - 28 March 2014,Barcelona, Spain.
Predictors of HIV-1 transmitted drug resistance and transmission networks in the Leuven cohort
Poster presentation by Andrea Clemencia Pineda
12th European Workshop on HIV & Hepatitis - Treatment Strategies & Antiviral Drug Resistance, 26 - 28 March 2014,Barcelona, Spain.
2013
Europe-wide increase of early detection of HIV-1 infection in MSM, but additional strategies are needed for other risk groups
Oral abstract presentation by Marije Hofstra
14th European AIDS Conference, October 16-19, 2013, Brussels, Belgium
Efficacy of tenofovir and efavirenz in combination with lamivudine or emtricitabine in antiretroviral-naïve patients in clinical practice in Europe
Oral abstract presentation by Justin Swartz
11th European Meeting on HIV & Hepatitis, March 22 2013, Rome, Italy
Prevalence of drug-resistant HBV in antiviral therapy experienced patients in Europe: Reports from the CAPRE study
Oral abstract presentation by Lucas Hermans
11th European Meeting on HIV & Hepatitis, March 21 2013, Rome Italy.
2012
HBV drug resistance in drug-experienced patients: A cumulative analysis of line probe assay results from a Dutch tertiary referral centre (2000-2011)
Poster presentation by Lucas Hermans
10th European Meeting on HIV & Hepatitis, 28-30 March 2012, Barcelona, Spain
2011
Transmission of HIV Resistant to Non-nucleoside RT Inhibitors Is Rising in MSM in Europe
Oral abstract presentation by Annemarie Wensing
13th European Aids Conference, October 12-15 2011, Belgrade – Serbia
Transmission of drug resistant HIV; global trends and implications for first line therapy
Invited lecture by Annemarie Wensing
6th International Workshop on HIV Transmission, 14 – 15 July 2011, Rome, Italy
Transmission of HIV resistant to non-nucleoside RT inhibitors is rising in Europe
Oral abstract presentation by Charles Boucher
6th International Workshop on HIV Transmission, 14 – 15 July 2011, Rome, Italy
The frequently transmitted M41L mutation in RT does not affect the in vitro selection of resistance against tenofovir and emtricitabine
Oral abstract presentation by Marieke Pingen
6th International Workshop on HIV Transmission 14 – 15 July 2011, Rome, Italy
